IQVIA Holdings Inc.

159.14-3.03-1.87%Vol 1.17M1Y Perf 8.54%
Oct 27th, 2020 16:04 DELAYED
BID150.00 ASK162.17
Open162.62 Previous Close162.17
Pre-Market- After-Market-
 - -%  - -%
Target Price
185.87 
Analyst Rating
Strong Buy 1.26
Potential %
16.80 
Finscreener Ranking
     40.66
Insiders Trans % 3/6/12 mo.
-67/-78/-89 
Value Ranking
     34.69
Insiders Value % 3/6/12 mo.
-91/-95/-98 
Growth Ranking
★★+     47.78
Insiders Shares Cnt. % 3/6/12 mo.
-91/-96/-98 
Income Ranking
 —    -
Market Cap30.51B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
82.10 
Earnings Date
20th Oct 2020

Today's Price Range

158.58162.74

52W Range

81.79176.00

5 Year PE Ratio Range

16.00145.60

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-6.50%
1 Month
7.22%
3 Months
2.40%
6 Months
23.01%
1 Year
8.54%
3 Years
50.68%
5 Years
135.92%
10 Years
-

TickerPriceChg.Chg.%
IQV159.14-3.0300-1.87
AAPL116.601.55001.35
GOOG1 604.2613.81000.87
MSFT213.253.17001.51
XOM32.83-0.5200-1.56
WFC21.82-0.8800-3.88
JNJ143.15-0.8200-0.57
FB283.296.18002.23
GE7.10-0.2800-3.79
JPM99.33-1.9100-1.89
Earnings HistoryEstimateReportedSurprise %
Q03 20201.411.506.38
Q02 20200.911.0313.19
Q01 20201.351.5011.11
Q04 20191.591.50-5.66
Q03 20191.441.493.47
Q02 20191.381.390.72
Q01 20191.411.431.42
Q04 20181.361.370.74
Earnings Per EndEstimateRevision %Trend
12/2020 QR1.855.11Positive
12/2020 FY5.853.17Positive
3/2021 QR1.795.29Positive
12/2021 FY7.282.97Positive
Next Report Date-
Estimated EPS Next Report1.41
Estimates Count8
EPS Growth Next 5 Years %11.00
Volume Overview
Volume1.17M
Shares Outstanding191.73M
Trades Count20.16K
Dollar Volume228.93M
Avg. Volume1.38M
Avg. Weekly Volume943.85K
Avg. Monthly Volume910.50K
Avg. Quarterly Volume959.29K

IQVIA Holdings Inc. (NYSE: IQV) stock closed at 162.17 per share at the end of the most recent trading day (a -3.13% change compared to the prior day closing price) with a volume of 1.30M shares and market capitalization of 30.51B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 65000 people. IQVIA Holdings Inc. CEO is Ari Bousbib.

The one-year performance of IQVIA Holdings Inc. stock is 8.54%, while year-to-date (YTD) performance is 4.99%. IQV stock has a five-year performance of 135.92%. Its 52-week range is between 81.79 and 176, which gives IQV stock a 52-week price range ratio of 82.10%

IQVIA Holdings Inc. currently has a PE ratio of 184.00, a price-to-book (PB) ratio of 5.49, a price-to-sale (PS) ratio of 2.93, a price to cashflow ratio of 18.30, a PEG ratio of 2.32, a ROA of 0.73%, a ROC of 2.60% and a ROE of 2.83%. The company’s profit margin is 1.78%, its EBITDA margin is 17.80%, and its revenue ttm is $10.96 Billion , which makes it $57.14 revenue per share.

Of the last four earnings reports from IQVIA Holdings Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.41 for the next earnings report. IQVIA Holdings Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for IQVIA Holdings Inc. is Strong Buy (1.26), with a target price of $185.87, which is +16.80% compared to the current price. The earnings rating for IQVIA Holdings Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

IQVIA Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

IQVIA Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.26, ATR14 : 4.89, CCI20 : -27.49, Chaikin Money Flow : -0.26, MACD : 2.21, Money Flow Index : 41.57, ROC : -2.75, RSI : 48.36, STOCH (14,3) : 14.58, STOCH RSI : 0.00, UO : 44.71, Williams %R : -85.42), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of IQVIA Holdings Inc. in the last 12-months were: Ari Bousbib (Sold 414 720 shares of value $65 536 984 ), John M. Leonard (Option Excercise at a value of $880 178), John M. Leonard (Sold 10 100 shares of value $1 565 500 ), John P. Connaughton (Sold 703 828 shares of value $115 638 944 ), Kevin C. Knightly (Sold 7 879 shares of value $1 297 107 ), Michael J. Evanisko (Option Excercise at a value of $644 970), Michael J. Evanisko (Sold 25 000 shares of value $3 969 375 ), Michael R. Mcdonnell (Sold 12 000 shares of value $1 860 840 ), Ronald E. Bruehlman (Buy at a value of $1 599 400), W. Richard Staub (Option Excercise at a value of $4 380 426), W. Richard Staub (Sold 34 917 shares of value $5 648 185 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
14 (82.35 %)
14 (82.35 %)
13 (81.25 %)
Moderate Buy
1 (5.88 %)
1 (5.88 %)
1 (6.25 %)
Hold
2 (11.76 %)
2 (11.76 %)
2 (12.50 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.26
Strong Buy
1.26
Strong Buy
1.28

IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The CRO segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The legacy IMS business provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers.

CEO: Ari Bousbib

Teplephone: +1 203 448-4600

Address: 83 Wooster Heights Road, Danbury 06810, CT, USA

Number of employees: 65 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

50%50%

Bearish Bullish

51%49%

News

Stocktwits